GSK’s ADC prospects brighten further with Hansoh’s second Phase III triumph
The positive results come as GSK looks to lean on its oncology pipeline and portfolio for future growth amid key patent expiries.
29 July 2026
29 July 2026
The positive results come as GSK looks to lean on its oncology pipeline and portfolio for future growth amid key patent expiries.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.